|
C6ORF153 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.863780E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.7600000000193E-06 |
| Normal-vs-Stage2 |
7.004200E-01 |
| Normal-vs-Stage3 |
5.714800E-01 |
| Normal-vs-Stage4 |
4.984400E-01 |
| Stage1-vs-Stage2 |
3.590200E-01 |
| Stage1-vs-Stage3 |
5.288400E-02 |
| Stage1-vs-Stage4 |
7.922000E-02 |
| Stage2-vs-Stage3 |
8.743200E-01 |
| Stage2-vs-Stage4 |
6.155000E-01 |
| Stage3-vs-Stage4 |
4.055400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.757570E-02 |
| Normal-vs-AfricanAmerican |
6.873400E-01 |
| Normal-vs-Asian |
7.637000E-01 |
| Caucasian-vs-AfricanAmerican |
2.816000E-01 |
| Caucasian-vs-Asian |
7.526800E-01 |
| AfricanAmerican-vs-Asian |
9.485200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.126300E-02 |
| Normal-vs-Female |
1.884640E-01 |
| Male-vs-Female |
3.192200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.843200E-03 |
| Normal-vs-Extreme_Weight |
8.139200E-03 |
| Normal-vs-Obese |
9.676800E-01 |
| Normal-vs-Extreme_Obese |
2.623200E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.104000E-01 |
| Normal_Weight-vs-Obese |
1.825200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.387600E-01 |
| Extreme_Weight-vs-Obese |
2.094400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.900420E-01 |
| Obese-vs-Extreme_Obese |
4.772400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.878600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.323900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.051210E-01 |
| Normal-vs-Age(81-100Yrs) |
1.297140E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.330170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.205160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.459000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.308200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.807800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.893500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.160600E-03 |
| Normal-VS-Type2 PRCC |
9.473600E-01 |
| Normal-VS-KIRP CIMP |
6.616600E-01 |
| Normal-VS-Unclassified PRCC |
2.336800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.896200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.027960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.665600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.831000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.596030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.548440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.831800E-02 |
| Normal-vs-N1 |
2.379000E-01 |
| Normal-vs-N2 |
3.196200E-03 |
| N0-vs-N1 |
6.377600E-02 |
| N0-vs-N2 |
5.324200E-01 |
| N1-vs-N2 |
2.332000E-01 |
|
|
